Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 47 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Risk stratification by circulating tumor DNA-based pretreatment genomic profile and post-operative molecular residual disease detection in resectable colorectal oligometastases: PRECISION, a prospective multicenter study
    S. Kobayashi, T. Takamoto, A. Shiomi +17
    ESMO OpenPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. Population-wide implementation of comprehensive cancer registration in Germany—overview article on current status quo and future perspectives
    B. Holleczek, S.-Z. Kim-Wanner, V. Arndt +3
    ESMO Real World Data and Digital OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. Discovering ferroptosis in biliary epithelium during liver fibrosis
    Romina Mancinelli, Arianna Casini, Stefano Leone +14
    European Journal of Histochemistry : EJHPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  4. SensReg: A Regulon-Based Predictor of Neoadjuvant Chemotherapy Response in ER- Positive/HER2-Negative Breast Cancer
    Bashir Lawal, Xiaosong Wang
    Research SquarePreprintCC BY 4.0Full textOncologyPMC
  5. Overcoming the Shield: Mechanisms of Resistance to DNA Repair Inhibitors and Strategies to Restore Synthetic Lethality
    Kannan Sridharan, Ondrej Fiala, Gowri Sivaramakrishnan +2
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  6. Integrative Multi-Omics and Single-Cell Analyses Identify FKBP10 as a CAF-Associated Biomarker Linked to ECM Remodeling and Aggressiveness in Neuroblastoma
    Zhaolong Wang, Baocheng Gong, Chaoyu Wang +7
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. Monitoring Molecular Residual Disease in Colorectal Cancer Using Tumor-Informed ctDNA Analysis
    William C. Cho, Yingyu Wang, Qianqian Yao +7
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  8. Hexokinases and Glial Tumor Metabolism: A Bridge between Bioenergetics and Translational Oncology
    Corina Ionela Tamas, Flaviu Tamas, Alina Roxana Cehan +1
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  9. Biochanin A Induces Cuproptosis and Inhibits Lung Metastasis in triple-negative Breast Cancer
    Limei Zhang, Yue Duan, Shuang Pu +8
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Pinin Modulation Restores Chemosensitivity in SW620 and HCT-116 Colon Cancer Cells
    Molli Alice, Buonvicino Daniela, Mattei Gianluca +10
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  11. Bone Metastasis and the Immunosuppressive Tumor Microenvironment: Mechanisms and Therapeutic Strategies
    Minghao Ba, Yuzhu Chen, Peng Jiang +3
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  12. Seven-Gene Signature and Immune Microenvironment as Determinants of Survival Rate in Colorectal Carcinoma
    Vincenzo Rallo, Matteo Massidda, Xiaofen Wen +12
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  13. Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study
    Paul J. Chen, Jung-Ju Lin, Wei-Lin Hsu +6
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  14. Single-Cell and Spatial Insights into Oral Squamous Cell Carcinoma: Towards Cell-State-Targeted Immunotherapy
    Yang Chen, Lirong Hou
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  15. A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity
    Yang Liu, Lixue Chen, Peng Wang +9
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Surgical Impact on Circulating Tumor and Hybrid Cells in Head and Neck Cancer: A Pilot Study
    Evgeniya S. Grigoryeva, Anna Y. Kalinchuk, Irina K. Fedorova +3
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  17. CXCL9 Knockdown Inhibits Tumor Progression and Angiogenesis in Clear Cell Renal Cell Carcinoma via JAK-STAT3 Signaling Pathway
    Shi Zong, Kaichen Wang, Yonggang Wang
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  18. LCN2: Potential Targets for Cancer via Ferroptosis-Related Pathways
    Juan Zhang, Ying Chen
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  19. Combined Expression of FOXO and Tribbles Proteins Predicts Survival of Glioma Patients
    Bruno F. Santos, Ana-Teresa Maia, Inês Grenho +4
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  20. Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations
    Lila A. Marshall, Natalie L. Ayoub, Jill Tseng +1
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  21. Tumor Microenvironment-Mediated Resistance in HER2-Positive Breast Cancer: Recent Advances and Therapeutic Challenges
    Yutong Zhang, Xuanyi Lv, Zhihong Deng +9
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  22. The Duffy-Null genotype and epithelial ovarian cancer survival in a cohort of Black women
    Joellen M. Schildkraut, Jeffrey R. Marks, Lauren C. Peres +16
    Gynecologic oncologyPeer-reviewedCC BY-NC-NDFull textOncologyPMC
  23. HHV-6 Encephalitis Presenting With Severe SIADH and CO2 Narcosis in Non-Transplant Smoldering Adult T-Cell Leukemia/Lymphoma
    Kana Tateishi, Toyoshi Yanagihara, Ryoma Kawabata +6
    The American Journal of Case ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  24. Immunostimulatory gene therapy with chemotherapy remodels pancreatic tumors and induces immune signatures associated with prolonged survival
    Jessica Wenthe, Hanna Grauers Wiktorin, Amanda Hahn +9
    Journal for Immunotherapy of CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  25. Epigenetic repression of oncogenic signaling defines immune-permissive tumor states associated with response to immune checkpoint inhibitors in advanced NSCLC
    María Gallardo-Gómez, Uxía Termenón-Rivas, Irene Alonso-Álvarez +10
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMC